Opening book details…
About this Medicine article
6LBA Phase 1 first-in-human study of the enhancer of zeste-homolog 2 (EZH2) histone methyl transferase inhibitor E7438 as a single agent in patients with advanced solid tumors or B cell lymphoma by Ribrag, V.; Soria, J.C.; Reyderman, L.; Chen, R.; Salazar, P.; Kumar, N.; Kuznetsov, G.; Keilhack, H.; Ottesen, L.H.; Italiano, A. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Ribrag, V.; Soria, J.C.; Reyderman, L.; Chen, R.; Salazar, P.; Kumar, N.; Kuznetsov, G.; Keilhack, H.; Ottesen, L.H.; Italiano, A.
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0959-8049)
- Published
- 2014
- Language
- EN
- Field
- Medicine (Health Sciences)